Stable synthetic phytase variants

JP2023550077A5Active Publication Date: 2024-11-22EW NUTRITION GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023528946
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-17
Filing Date
2021-11-17
Publication Date
2024-11-22
Estimated Expiration
2041-11-17

AI Technical Summary

Technical Problem

Existing phytases used in animal feed are prone to denaturation by heat, leading to reduced enzyme activity and efficacy, and existing stabilization methods are complex or have limitations such as suboptimal activity and specificity.

Method used

Development of stable phytase variants through enzyme shuffling, combining biobricks from Obesumbacterium and Hafnia phytases to enhance thermostability and protease resistance, using molecular modeling and biobrick reassembly techniques.

Benefits of technology

The resulting synthetic phytases exhibit improved thermostability and protease resistance, maintaining activity under high temperatures and gastric conditions, enhancing the effectiveness of animal feed applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The present invention relates to a synthetic phytase that is a shuffling product comprising biobricks of at least two reference phytases from the genera Obesambacterium and / or Hafnia (Figure 1).
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates to the field of phytases. [Background technology]

[0002] Phytase (myo-inositol hexaphosphate phosphohydrolase) is a phosphatase enzyme that catalyzes the hydrolysis of phytic acid (myo-inositol hexaphosphate) to release usable inorganic phosphorus. Phytic acid is a non-digestible organic phosphorus found in grains and oilseeds. Phytases have been found in animals, plants, fungi, and bacteria. Phytases used in animal feed applications were initially derived from fungi, but today bacterial enzymes predominate. Phytases can be grouped based on their pH activity optimum (as acid or alkaline phytases), their catalytic mechanism and enzyme fold (as histidic, cysteine, or purple acid phosphatases, or as β-propeller phytases), or their stereoselectivity for phytate degradation (as 3- or 6-phytases). The EC database takes this stereoselectivity into account by defining two classes: 3.1.3.8 and 3.1.3.26. These two classes are commercially used. Phytases belonging to groups 3.1.3.72 (PTP-like phytases) and 3.1.3.2 (purple acid phosphatases) are rare and not commercially available.

[0003] Phytic acid and its metabolites play several important roles in seeds and grains. In particular, phytic acid functions as a phosphorus storage reservoir, an energy reservoir, a source of cations, and a source of myo-inositol (a precursor to cell walls). Phytic acid is the primary storage form of phosphorus in plant seeds and the primary source of phosphorus in grain-based feeds used in intensive livestock farming. While the organic phosphates contained in phytic acid are largely unavailable to ingesting animals, the inorganic phosphates released by phytase are readily absorbed. Ruminants can utilize phytic acid as a phosphorus source because bacteria living in their gut are well known to produce many types of phytase.

[0004] However, monogastric animals cannot utilize phytate as a major phosphorus source because their gastrointestinal microflora does not produce enough phytase, which is excreted in the feces.

[0005] In ruminants (cattle, sheep), phytase is produced by intestinal bacteria, allowing them to utilize phytic acid in grains as a phosphorus source. Non-ruminant (monogastric) animals, such as humans, dogs, and birds, do not produce phytase. Research in the field of animal nutrition has promoted the idea of ​​adding phytase to feed to enable animals to utilize nutrients bound by phytic acid, such as calcium, phosphorus, other minerals, carbohydrates, and protein.

[0006] Phytase is often used as a feed additive for poultry and pigs to enhance the nutritional value of plant materials by liberating inorganic phosphate from phytic acid (myo-inositol hexaphosphate). Phytase can be purified from genetically modified microorganisms and has recently been produced in genetically modified rapeseed, alfalfa, and rice plants. Phytase can also be produced on a large scale by cellulosic biomass fermentation using genetically modified (GM) yeast.

[0007] For many applications, improved enzyme stability is an important advantage: since phytases are often subjected to heat treatment during production, improved thermostability helps to improve the processability of phytases.

[0008] This is especially true for the use of phytase in animal feed. During feed processing, the feed is often subjected to heat, for example by the application of steam, to reduce or eliminate pathogens, extend the feed's shelf life, and optimize ingredient utilization, leading to improved feed conversion. Conditioning times vary from a few seconds to a few minutes, depending on the feed type and formulation. Temperatures during conditioning typically range from 70°C to 100°C. After conditioning, the feed may be extruded through a pelleting die, which causes a rapid temperature increase due to heat dissipation caused by friction.

[0009] However, in other applications, phytase enzymes are also exposed to heat. Because phytase is a protein, it is susceptible to denaturation by heat and pressure. Denaturation essentially changes the structure of the enzyme, resulting in a lower activity level and reduced enzyme efficacy.

[0010] There are various ways to improve the stability of phytase or to protect it from heat effects. For animal feed applications, post-pelleting liquid application is one option, but it is relatively complex and expensive, requiring the purchase and installation of specialized equipment, space to store the liquid enzyme, and careful calculation of the amount of enzyme to be applied.

[0011] Another option is to apply a protective coating to synthetic phytase before pelleting it with other ingredients (e.g., feed). This method, described for example by Partridge (2007), may reduce the efficacy of the enzyme because the coating may not completely dissolve in the animal's digestive tract. Furthermore, it is difficult to design a coating that can withstand the high heat and moisture content of the pelleting process and subsequently dissolve under lower temperature and high moisture conditions, such as in the animal's intestine.

[0012] Another option is to use inherently thermostable phytases. These phytases, theoretically derived from thermophilic or hyperthermophilic bacteria, have unique structures and functions that allow for high thermostability. However, these phytases may suffer from limitations such as suboptimal activity, specificity, bioavailability, pH range, and processability. Summary of the Invention [Problem to be solved by the invention]

[0013] Therefore, one object of the present invention is to provide stable phytase variants that are not subject to the above-mentioned limitations.

[0014] These and other objects are achieved according to the invention by the methods and means set forth in the independent claims. The dependent claims relate to specific embodiments. [Brief explanation of the drawings]

[0015] [Figure 1] The structure of phytic acid [Figure 2] Scheme of the reaction catalyzed by phytase [Figure 3] Schematic diagram showing the properties of several synthetic (shuffled) phytase enzymes according to the present invention and their respective wild-type (reference) phytases. See Examples 2-5 for experimental descriptions of each. In one embodiment of the present invention, thermostability may be prioritized over protease stability or pH stability. This means that for a given shuffling product, a slight loss in protease or pH stability can be tolerated (e.g., a loss of -10% or -20%) if a significant increase in IT50 is achieved. For example, OHO has excellent thermostability (IT50), but only a slight decrease in resistance to pepsin digestion. [Figure 4] Two schemes for the shuffling process and subsequent mutagenesis [Figure 5] Alignment of the amino acid sequences of phytases from Hafnia alvei (SEQ ID NO: 1) and Obesumbacterium proteus (SEQ ID NO: 2), showing 73.8% sequence identity. In addition to Obesumbacterium proteus, there are other bacterial phytases that are evolutionarily close to the Hafnia alvei phytase, and are within the same range of identity. These similar phytases belong to the Enterobacteriaceae family, including bacteria from the genus Buttiauxella and Escherichia coli. Of these evolutionarily close phytases, the Obesum proteus phytase was specifically selected for the shuffling process with the Hafnia alvei phytase. [Figure 6]Alignment of the amino acid sequences of Hafnia alvei phytase (SEQ ID NO: 1) and the shuffling product OHO (SEQ ID NO: 3). Underlined amino acids represent the biobrick from Obesumbacterium proteus, while bolded amino acids represent the biobrick from Hafnia alvei. [Figure 7] Figure 3 shows the experimental results in graph form. DETAILED DESCRIPTION OF THE INVENTION

[0016] Before describing the present invention in detail, it is to be understood that the present invention is not limited to the specific components or structural features of the described devices or compositions, or method steps of the described methods, as such devices and methods may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage. Any reference signs in the claims are not to be construed as limiting the scope. It should be noted that, as used in the specification and the appended claims, the singular forms "a," "an," and "the" include singular and / or plural references unless the context clearly dictates otherwise. Furthermore, in the claims, the word "comprising" does not exclude other elements or steps.

[0017] Furthermore, when a parameter range bounded by numerical values ​​is given, it will be understood that the range is intended to be inclusive of those limits.

[0018] Furthermore, it should be understood that the embodiments disclosed herein are not meant to be understood as separate, unrelated embodiments. Features discussed in one embodiment are meant to be disclosed in relation to other embodiments shown herein. In one case, if a particular feature is not disclosed in one embodiment but is disclosed in another embodiment, those skilled in the art will understand that this does not necessarily mean that the feature is not disclosed in the other embodiments. Those skilled in the art will understand that while it is the intent of the present application to disclose the feature in other embodiments as well, this has not been done merely for the sake of clarity and to keep the description manageable.

[0019] According to one aspect of the present invention there is provided a synthetic phytase which is a shuffling product comprising biobricks of at least two reference phytases from the genera Obesambacterium and / or Hafnia.

[0020] Based on the molecular modeling process disclosed herein, the inventors have found that phytases from the genera Obesambacterium and Hafnia are very promising starting points (domain structure, sequence similarity, etc.) for obtaining functional shuffling constructs with potentially improved stability.

[0021] The term "biobrick" as used herein refers to a standardized construct consisting of DNA sequences that are fragments of larger DNA, cDNA, RNA, or mRNA sequences that encode proteins with specific, defined functions. "Biobricks" exhibit the same cleavage sites, allowing for easy assembly. Here, the DNA sequences used encode phytase enzymes and are used as building blocks to reassemble DNA encoding synthetic "shuffled" phytase enzymes. More precisely, the DNA sequences of Obesambacterium and / or Hafnia that encode the respective phytase enzymes are used as building blocks to reassemble the synthetic "shuffled" phytase enzymes.

[0022] The term "reference phytase", as used herein, relates to a DNA, cDNA, RNA or mRNA sequence encoding a phytase enzyme, or the encoded phytase enzyme, that is used as a starting point for a method, as a source of such a biobrick.

[0023] As used herein, a "shuffling product" is an enzyme composed of two or more such bio-bricks from at least two different reference phytases, in which the bio-bricks of the different reference phytases have been reassembled in a specific or random order to alter the properties of the reference phytases.

[0024] In one embodiment, different reference phytases are fragmented to obtain biobricks of corresponding function, orientation in the reference phytase, and / or similar length.

[0025] For example, fragmentation of reference phytase A yields BioBricks 1, 2, and 3, while fragmentation of reference phytase B yields the corresponding BioBricks 1', 2', and 3'.

[0026] Biobricks 1 and 1', Biobricks 2 and 2', and Biobricks 3 and 3' are referred to as "corresponding Biobricks" because they each have corresponding functions, orientations in the reference phytase, and / or similar lengths.

[0027] In one embodiment, during reassembly, one member of each set of corresponding biobricks is selected and the selected biobricks are combined to reproduce the orientation of the different biobricks in one of the reference phytases, e.g., 1'-2-3, 1-2'-3, etc.

[0028] In one embodiment, the process itself does not introduce any "new" amino acid residues or substitutions beyond those made in the simple shuffling process, and as a result, the resulting shuffling products contain no "new" amino acid residues or substitutions beyond those made in the simple shuffling process.

[0029] Enzyme shuffling methods are disclosed, for example, in Engler et al. (2009), the contents of which are incorporated herein by reference.

[0030] The genera Obesambacterium and Hafnia are both Gram-negative bacteria in the family Hafniaceae of the order Enterobacteriaceae.

[0031] In one embodiment, the reference phytase is a wild-type phytase of the genus Obesambacterium and / or Hafnia. In another embodiment, the "reference phytase" is a mutant phytase derived from said wild-type phytase, e.g., a variant having at least one amino acid substitution compared to such wild-type phytase or having at least 80% sequence identity with such wild-type phytase while maintaining phytase activity.

[0032] In preferred embodiments, the mutant phytase has ≧81, ≧82, ≧83, ≧84, ≧85, ≧86, ≧87, ≧88, ≧89, ≧90, ≧91, ≧92, ≧93, ≧94, ≧95, ≧96, ≧97, ≧98, and most preferably ≧99% sequence identity with the wild-type phytase.

[0033] In a preferred embodiment, the mutant phytase has 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, and having 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82 or 83 amino acid substitutions.

[0034] According to one embodiment, the at least one reference phytase is or is derived from a wild-type phytase of Hafnia alvei and / or Obesambacterium proteus.

[0035] The term "derived from" relates to an enzyme variant which has at least one amino acid substitution compared to a wild-type phytase or which has at least 80% sequence identity with such a wild-type phytase while retaining phytase activity.

[0036] In preferred embodiments, the enzyme variant has ≧81, ≧82, ≧83, ≧84, ≧85, ≧86, ≧87, ≧88, ≧89, ≧90, ≧91, ≧92, ≧93, ≧94, ≧95, ≧96, ≧97, ≧98, and most preferably ≧99% sequence identity with said wild-type phytase.

[0037] In a preferred embodiment, the enzyme variant has 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 12 and having 0, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82 or 83 amino acid substitutions.

[0038] According to one embodiment, the at least one reference phytase comprises at least one of the following: a) the amino acid sequence set forth in SEQ ID NO: 1 or 2 (“wild-type phytase”) b) an amino acid sequence according to option a), with the proviso that it has at least one amino acid substitution with respect to each SEQ ID NO: defined in a) while maintaining its phytase activity; c) An amino acid sequence according to option a), with the proviso that it has at least 80% sequence identity to the respective SEQ ID NO: provided in a), while maintaining its phytase activity.

[0039] In a preferred embodiment, the enzyme variant has ≧81, ≧82, ≧83, ≧84, ≧85, ≧86, ≧87, ≧88, ≧89, ≧90, ≧91, ≧92, ≧93, ≧94, ≧95, ≧96, ≧97, ≧98, most preferably ≧99% sequence identity to the respective SEQ ID NOs defined in a).

[0040] In a preferred embodiment, the enzyme variants are selected from the group consisting of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, and having 9, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82 or 83 amino acid substitutions.

[0041] "Percentage of sequence identity" is determined by comparing two optimally aligned sequences over a comparison window, where the portion of the polynucleotide sequence in the comparison window may contain additions or deletions (i.e., gaps) compared to a reference sequence (e.g., a polypeptide) that does not contain additions or deletions due to optimal alignment of the two sequences. The percentage is calculated by determining the number of positions where the same nucleic acid base or amino acid residue occurs in both sequences to obtain the number of matching positions, dividing the number of matching positions by the total number of positions in the comparison window, and multiplying the result by 100 to obtain the percentage of sequence identity.

[0042] The terms "identical" or percent "identity," with respect to two or more nucleic acid or polypeptide sequences, refer to two or more sequences or subsequences that are the same sequence. Two sequences are "substantially identical" if they have a specified percentage of the same amino acid residues or nucleotides (i.e., at least 85%, 90%, 95%, 96%, 97%, 98%, 99% sequence identity over a specified region, or, if not specified, the entire reference sequence), when compared and aligned for maximum correspondence over a comparison window, or designated region, measured using one of the sequence comparison algorithms described below, or by manual alignment and visual inspection.

[0043] The BLAST algorithm is one of the algorithms suitable for determining sequence identity. Another algorithm for determining sequence identity is the Clustal Omega algorithm.

[0044] The disclosure provides polypeptides or polynucleotides that are substantially identical to the polypeptides or polynucleotides, respectively, exemplified herein. In some cases, identity exists over a region at least about 15, 25, or 50 nucleotides in length, or more preferably over a region 100 to 500 or 1000 or more nucleotides in length, or over the entire length of the reference sequence. With respect to amino acid sequences, identity or substantial identity can exist over a region at least 5, 10, 15, or 20 amino acids in length, in some cases at least about 25, 30, 35, 40, 50, 75, or 100 amino acids in length, in some cases at least about 150, 200, or 250 amino acids in length, or over the entire length of the reference sequence. With respect to shorter amino acid sequences, e.g., sequences of 20 or fewer amino acids, substantial identity exists when one or two amino acid residues are conservatively substituted according to conservative substitutions as defined herein.

[0045] According to one or more embodiments of the invention, at least one of the amino acid substitutions discussed above is a conservative amino acid substitution.

[0046] "Conservative amino acid substitutions" have less impact on enzyme function than non-conservative substitutions. Amino acids can be classified in various ways, but they are often divided into six major groups based on their structure and the general chemical properties of their R groups.

[0047] In one embodiment, a "conservative amino acid substitution" is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. For example, families of amino acid residues having similar side chains have been defined in the art. These families include: Basic side chains (lysine, arginine, histidine, etc.), acidic side chains (aspartic acid, glutamic acid, etc.), Uncharged polar side chains (glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine, etc.), Nonpolar side chains (alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan, etc.), β-branched side chains (threonine, valine, isoleucine, etc.), Amino acids with aromatic side chains (such as tyrosine, phenylalanine, tryptophan, and histidine) are included.

[0048] Other conservative amino acid substitutions can also occur across amino acid side chain families, such as when substituting asparagine for aspartic acid to modify the charge of the peptide. Thus, for example, a predicted non-essential amino acid residue in an HR domain polypeptide is preferably substituted across families with another amino acid residue from the same side chain family or homolog (e.g., asparagine for aspartic acid, glutamine for glutamic acid). Conservative changes can also include the substitution of chemically homologous non-natural amino acids (i.e., a synthetic non-natural hydrophobic amino acid for leucine, a synthetic non-natural aromatic amino acid for tryptophan).

[0049] As used herein, the term "maintaining phytase activity" means, for example, that the respective variant has 50% or more phytase activity compared to the phytase activity of the wild-type phytase sequence. According to one embodiment, the synthetic phytase has any of the following shuffling structures shown in the N→C orientation: O / H / O H / H / O, and / or O / H / H where O represents the biobrick from the Obesumbacterium sp. reference phytase and H represents the biobrick from the Hafnia sp. reference phytase.

[0050] The following table outlines desirable building block lengths: JPEG2023550077000002.jpg46170

[0051] According to one embodiment, the synthetic phytase comprises one of the following: a) An amino acid sequence set forth in any one of SEQ ID NOs: 3 to 5 ("shuffled sequence") b) an amino acid sequence according to option a), with the proviso that it has at least one amino acid substitution with respect to the respective SEQ ID NO: defined in a) while maintaining its phytase activity; c) An amino acid sequence according to option a), with the proviso that the sequence has 80% or more sequence identity to each of the SEQ ID NOs defined in a), while maintaining its phytase activity.

[0052] The above synthetic phytase is a shuffling product containing bioblocks of the Obesambacterium sp. reference phytase and the Hafnia sp. reference phytase. Surprisingly, the synthesized phytase exhibits thermostability (IT) compared to the reference phytases. 50 ) was improved. 50 The value was approximately 63°C, and the IT of the reference phytase from Obesambacterium sp. 50 Although the thermostability of the three shuffling products was approximately 60°C, all of them exceeded the thermostability of the reference phytase from Hafnia sp. 50 The mean values ​​were not shown.

[0053] In a preferred embodiment, the enzyme variant has ≧81, ≧82, ≧83, ≧84, ≧85, ≧86, ≧87, ≧88, ≧89, ≧90, ≧91, ≧92, ≧93, ≧94, ≧95, ≧96, ≧97, ≧98, most preferably ≧99% sequence identity to the respective SEQ ID NOs defined in a).

[0054] In a preferred embodiment, the enzyme variants are selected from the group consisting of 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, and having 9, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82 or 83 amino acid substitutions.

[0055] According to one or more embodiments of the invention, at least one of the amino acid substitutions discussed above is a conservative amino acid substitution.

[0056] According to one embodiment, the synthetic phytase has improved stability compared to one of the reference phytases.

[0057] According to one embodiment, said increased stability is characterized by an increased thermostability (IT) compared to one of the reference phytases. 50 ) The IT50 values ​​of the reference phytases are as follows: JPEG2023550077000003.jpg12170

[0058] As used herein, the term "thermostable" refers to the ability of an enzyme to have equal or greater activity than the wild-type under standard conditions, and to an increased ability to retain activity after exposure to elevated temperatures.

[0059] According to one embodiment, the synthetic phytase is heated at 60°C or above IT 50 According to further embodiments, the synthetic phytase has an IT of ≥ 65°C, ≥ 70°C, ≥ 75°C, ≥ 80°C, or ≥ 85°C. 50 It has.

[0060] According to one embodiment, the synthetic phytase is at an IT temperature of 110°C or less.50 According to further embodiments, the synthetic phytase has an IT of ≦105° C.; ≦100° C.; or ≦98° C. 50 It has.

[0061] According to one embodiment, the synthetic phytase is fermented at an IT temperature of 60°C or higher and 110°C or lower. 50 According to further embodiments, the synthetic phytase has an IT between ≥ 65°C and ≤ 105°C, ≥ 70°C and ≤ 100°C, ≥ 75°C and ≤ 98°C, ≥ 80°C and ≤ 98°C, or ≥ 85°C and ≤ 98°C. 50 It has.

[0062] According to one embodiment, said increased stability is increased stability against protease digestion (also called "protease resistance") compared to one of a reference phytase.

[0063] Stability to protease digestion can be measured by exposure to protease K1 (Kumamolisin AS1, described in WO2017220776A1). Such stability is very important because phytases are often combined with proteases for specific purposes. Therefore, there is a risk that the proteases may inactivate or digest the phytase added at the same time.

[0064] Additionally or alternatively, stability to protease digestion can be measured by exposure to the protease pepsin. Such stability is crucial for feed applications, as phytases must survive and remain active in the stomach environment where pepsin is present and active. Therefore, there is a risk that proteases may inactivate or digest phytases added at the same time.

[0065] As a result of the enzyme optimization process, optimizing one parameter can affect other parameters, for example, increasing the thermostability while simultaneously increasing or decreasing the stability or pH stability of the protease.

[0066] For animal feed phytases, in one embodiment, thermostability may be prioritized over protease stability or pH stability, meaning that for a given shuffling product, a small loss in protease or pH stability may be tolerated (e.g., a -10% or -20% loss) if a large increase in IT50 is achieved.

[0067] According to one embodiment, said increased stability is an increased pH stability (also called "pH tolerance") compared to one of a reference phytase.

[0068] As used herein, the term "pH stable" means that the enzyme has equal or greater activity than the wild-type under standard conditions and has an increased ability to retain activity after exposure to acidic conditions (e.g., pH 4.0 or less).

[0069] In accordance with another aspect of the present invention, there is provided a nucleic acid molecule encoding a synthetic phytase according to the above description.

[0070] In one embodiment, such nucleic acid molecules are codon-optimized for expression from eukaryotic hosts, preferably from the group of yeasts and fungi, most preferably Pichia pastoris, Aspergillus sp. and Trichoderma sp.

[0071] Codon optimization is a useful technique for improving heterologous protein expression. In fact, there are significant differences in codon usage between the host cell genome sequence and the native heterologous protein coding sequence, which clearly affects recombinant protein expression. It has been reported that optimizing heterologous protein coding sequences based on the codon bias of the host cell often results in an average increase of 1–5-fold in target protein production.

[0072] Codon optimization is a species-specific process, and those skilled in the art can derive a suitable codon optimization scheme for a given expression host from the respective literature. Respective teachings are provided, for example, in Yu et al. (2013), Rosemary et al. (2017), and Yang and Liu (2010), the contents of which are incorporated herein by reference for purposes of validity.

[0073] According to another aspect of the invention, there is provided a plasmid or vector system comprising the nucleic acid molecule.

[0074] According to another aspect of the present invention, there is provided a host cell capable of heterologous protein expression, said host cell comprising a plasmid or vector system comprising a nucleic acid molecule according to the above description.

[0075] According to yet another aspect of the present invention, heterologous protein expression is achieved by inserting the nucleic acid molecule into the genome of the host cell using state-of-the-art techniques based on homologous recombination or genome editing using programmable nucleases, such as CRISPR-Cas, Zn-finger or TAL endonucleases.

[0076] In different embodiments, such host cells are at least one selected from bacterial cells, fungal cells or yeast cells.

[0077] Exemplary bacterial cells include Escherichia coli and other Enterobacteriaceae, Escherichia, Campylobacter, Wolinella, Desulfovibrio, Vibrio, Pseudomonas, Bacillus, Bacteroides, Listeria, Staphylococcus, Streptococcus, Peptostreptococcus, Megasphaera, Pectinatus, Selenomonas, Zymophilus, Actinomyces, Arthrobacter, Frankia, Micromonospora, Nocardia, Propionibacterium, Streptomyces, Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, Acetobacterium, Agrobacterium, and the like. Genus Terium, Genus Alivibrio, Genus Eubacterium, Genus Haloarcula, Genus Halobacterium, Genus Heliobacterium, Genus Heliospirillum, Genus Sporomus, Genus Spiroplasma, Genus Ureaplasma, Genus Powdery Mildew (Erysipelothrix), Genus Corynebacterium, Genus Enterococcus, Genus Clostridium, Genus Mycoplasma, Genus Mycobacterium, Genus Actinobacteria, Genus Salmonella, Genus Shigella, Genus Moraxella, Genus Helicobacter, Genus Paracoccidioides, Genus Stenotrophomonas, Genus Micrococcus, Genus Neisseria, Genus Bdellovibrio, Genus Haemophilus, Genus Thermus, Genus Klebsiella, Genus Proteus, Genus Enterobacter, Genus Serratia, Genus Citrobacter Examples of suitable bacterial species include α-proteobacteria such as Pseudomonas, Proteus, Rhodobacter, Rhodopseudomonas, Rhodospirillum, Serratia, Yersinia, Acinetobacter, Actinobacillus, Bordetella, Brucella, Capnocytophaga, Cardiobacterium, Eikenella, Francisella, Haemophilus, Kingella, Pasteurella, Flavobacterium, Xanthomonas, Burkholderia, Aeromonas, Plesiomonas, Legionella, and Wolbachia, as well as species of Comamonas, Pyrobaculum, and Sinorhizobium, cyanobacteria, spirochetes, green sulfur bacteria, green non-sulfur bacteria, gram-negative cocci, and gram-negative bacilli. In a preferred embodiment, the bacterial cell is Bacillus subtilis.

[0078] Exemplary fungal or yeast cells include species of the genera Pichia, Aspergillus, Kluyveromyces, Saccharomyces, Candida, Trichoderma, Penicillium, Neurospora, Chrysosporium, Cladosporium, Phytophthora, and Scytalidium, and more preferably Saccharomyces cerevisiae, Pichia pastoris, Aspergillus nidulans, Aspergillus niger, Trichoderma reesei, Kluyveromyces lactis, Kluyveromyces marxianus, and Neurospora crassa.

[0079] In a preferred embodiment, the yeast cell is Pichia pastoris, a methylotrophic yeast also known as Komagataella phaffii, that is widely used as a eukaryotic production host for recombinant protein expression.

[0080] In a further embodiment, such a host cell is a eukaryotic host cell selected from the group consisting of a plant cell, an insect cell or a mammalian cell.

[0081] According to another aspect of the present invention there is provided a feed additive, feed ingredient, feed supplement and / or feed comprising a synthetic phytase according to the above description.

[0082] According to another aspect of the present invention, there is provided the use of a synthetic phytase according to the above description for the production of animal feed. According to another aspect of the present invention, there is provided a process for developing a synthetic phytase according to the above description, the process comprising the steps of: a) providing two or more DNA, cDNA, RNA or mRNA sequences encoding at least two reference phytases from the genera Obesambacterium and / or Hafnia; b) digesting two or more DNA, cDNA, RNA or mRNA sequences with a type II restriction enzyme to generate DNA, cDNA, RNA or mRNA stretches that are fragments of the DNA, cDNA, RNA or mRNA sequences of step a); c) ligating the DNA, cDNA, RNA or mRNA substretches using a ligase enzyme to create at least one shuffled DNA, cDNA, RNA or mRNA sequence encoding a shuffled phytase enzyme; and d) Optionally, expressing said shuffled DNA, cDNA, RNA or mRNA sequences in a suitable expression system.

[0083] In one embodiment, steps b) to c) are repeated two or more times.

[0084] Type II restriction enzymes are preferably Type IIS restriction enzymes, preferably BsaI, BsmBI, or BbsI. Unlike standard Type II restriction enzymes such as EcoRI and BamHI, these enzymes cleave DNA outside of their recognition sites, creating non-palindromic overhangs. With 256 possible overhang sequences, multiple DNA fragments can be assembled by combining the overhang sequences.

[0085] The ligase is preferably T4 DNA ligase.

[0086] The restriction step b) is preferably carried out at a temperature of 35-40°C (preferably 37°C), and the ligation step c) is preferably carried out at a temperature of 10-20°C (preferably 16°C).

[0087] In one embodiment, this process is carried out in a thermal cycler, using a protocol that rocks between, for example, 37°C (for restriction) and, for example, 16°C (for ligation).

[0088] According to one embodiment, the process further comprises the following steps: e) mutating the DNA, cDNA, RNA or mRNA sequence encoding the shuffled phytase enzyme as described above to obtain one or more mutant phytase sequences; f) expressing one or more of the variant phytase sequences thus obtained in a suitable expression system to obtain one or more variant phytase enzymes; and g) Testing the stability, preferably the thermostability, of one or more variant phytase enzyme sequences.

[0089] Experiments and drawings While the present invention has been illustrated and described in detail in the drawings and the foregoing description, such illustration and description should be considered exemplary or illustrative and not restrictive, and the present invention is not limited to the disclosed embodiments. Other variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, disclosure, and appended claims. No reference signs should be construed as limiting the scope. All amino acid sequences disclosed herein are shown from N-terminus to C-terminus; all nucleic acid sequences disclosed herein are shown 5'->3'.

[0090] Example 1. Design of a semi-rational library of shuffled enzymes Based on a multiple structure-based alignment of the histidate phytase superfamily using the 3DM system (Bio Prodict, Nijmegen, NL), phytases belonging to the same protein family but possessing distinct beneficial traits were clustered. The phytase cluster was then analyzed for potential fragmentation sites. These fragmentation sites were selected at amino acid positions conserved across all proteins in the cluster, located outside helices and beta-sheets, and located near or adjacent to proline (three amino acids). The library consisted of at least two proteins and ultimately consisted of two or more fragments, called biobricks.

[0091] During this process, phytases from the genera Obesambacterium and Hafnia were found to be the most promising starting points (domain structure, sequence similarity, etc.) to obtain functional shuffling constructs with increased stability.

[0092] Biobricks are generated by PCR, introducing type IIs restriction sites that generate sequence-specific overhangs. Recombination of these biobricks maintains the sequence of structural elements and does not introduce amino acid changes or extra amino acids into the biobrick. This procedure further ensures that biobricks from different parent backbones are not discriminated against or preferentially integrated, thereby ensuring that the process yields all possible combinations.

[0093] This method can generally be used to recombine homologous proteins, at least one of which must have a solved crystal structure, from which the structure of the homologous protein can be deduced by homology comparison, such as structure-based alignment.

[0094] Three domains were selected for recombination of different bacterial phytases: the proline at the end of the selected protein domain was chosen as the recombination site;

[0095] Example 2: Phytase activity measurement JPEG2023550077000004.jpg82170

[0096] Samples were diluted according to volumetric activity with ddH2O containing 0.01% Triton-X-100. The diluted samples were assayed in a Nunc 384-well clear flat-bottom plate. The reaction was initiated by adding 1 part diluted sample to 1 part assay buffer and incubated at 37°C for 30 minutes in a thermoshaker. The reaction was then terminated by adding an equal volume of stop solution. The color reaction was initiated by adding an equal volume of color reagent solution and incubating at 25°C in the dark for 20 minutes. The absorbance at 650 nm was measured, and the amount of phosphate liberated by phytase was assessed against an inorganic phosphate standard curve measured under the same conditions.

[0097] Example 3: IT50 IT50 defines the temperature at which 50% of the activity is inactivated under the conditions shown below and is an indicator of thermostability in applications such as pelleting conditions, although it is not equivalent. JPEG2023550077000005.jpg37170

[0098] The supernatant of a submerged culture of a bacterial or fungal strain producing the desired phytase or phytase variant was diluted in a thermal incubation buffer. A 50 μl aliquot was incubated in a PCR machine at an appropriate temperature gradient for 10 minutes. Another aliquot was incubated at 25°C. After thermal incubation, the samples were kept at 25°C and the residual activity was measured using the phytase activity assay described in Example 2. The results are shown in Table 3 and Figure 7A.

[0099] Example 4: pH Activity Profile JPEG2023550077000006.jpg104170

[0100] The supernatant of a sedimentation culture of bacteria or fungi producing the desired phytase or phytase variant was diluted with dilution buffer according to volume activity. Activity was measured according to the assay described in Example 1, changing the assay buffer to the required pH. The reaction was initiated by adding 8 parts of one of the above buffers, allowing activity measurements at ambient pHs from 2.0 to 7.0. The reaction was stopped, and inorganic phosphate was measured as described in Example 2. The results are shown in Table / Figure 3.

[0101] Example 5: pH / Pepsin / K1 Stability This procedure provides information on the resistance to acid proteases as residual activity. The acid proteases tested were pepsin and the acid protease Kumamolisin AS (K1; see, e.g., European Patent Publications EP16206367 and EP16176044, the contents of which are incorporated herein by reference), as representatives of the acid proteases of the protease families S53 and G1. JPEG2023550077000007.jpg102170

[0102] One part of the supernatant from a submerged culture of a bacterial or fungal strain producing the phytase or phytase variant of interest was diluted with one part of the above buffer and tested for stability to acidic pH, acidic pH and pepsin, or acidic pH and protease K1. Assays were incubated at 37°C for 30 minutes. Residual activity was measured immediately after incubation as described in Example 2. The results are shown in Table / Figure 3 and Figure 7A.

[0103] References The contents of the prior art documents referred to in this specification are incorporated by reference. This refers in particular to prior art documents that disclose standard or conventional methods. In that case, incorporation by reference is intended to provide a fully enabling disclosure and to avoid lengthy repetition. JPEG2023550077000008.jpg154170

[0104] Sequence Listing The following sequences form part of the disclosure of this application. A WIPO ST 25 compatible electronic sequence listing is also provided with this application. For the avoidance of doubt, in the event of any discrepancy between a sequence in the table below and a sequence in the electronic sequence listing, the sequence in the table shall be deemed correct. JPEG2023550077000009.jpg179170

Claims

1. A synthetic phytase which is a shuffling product comprising a biobrick of at least two reference phytases from the genera Obesambacterium and / or Hafnia, Synthetic phytase a) The amino acid sequence set forth in SEQ ID NO:3 ("shuffle sequence") b) an amino acid sequence according to option a), which has a sequence identity of 90% or more to SEQ ID NO: 3 as defined in a), while maintaining phytase activity; 5. A synthetic phytase comprising any one of:

2. 2. The synthetic phytase of claim 1, having increased stability compared to one of the reference phytases.

3. The increased stability is due to increased thermostability (IT) compared to one of the reference phytases. 50 3. The synthetic phytase of claim 2, wherein

4. IT 50 The synthetic phytase of claim 3, wherein the temperature is 60°C or higher and 100°C or lower.

5. 3. The synthetic phytase of claim 2, wherein the increased stability is increased stability against protease digestion compared to one of the reference phytases.

6. 3. The synthetic phytase of claim 2, wherein the increased stability is increased pH stability compared to one of a reference phytase.

7. A nucleic acid molecule encoding a synthetic phytase according to any one of claims 1 to 6.

8. A plasmid or vector system comprising the nucleic acid molecule of claim 7.

9. A host cell capable of heterologous protein expression, said host cell comprising a plasmid or vector system according to claim 8 or a nucleic acid molecule according to claim 7.

10. A feed additive, feed ingredient, feed supplement and / or feed comprising the synthetic phytase of any one of claims 1 to 6.

11. Use of the synthetic phytase according to any one of claims 1 to 6 for the manufacture of a feedstuff.